High cumulative JC virus seroconversion rate during long-term use of natalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High cumulative JC virus seroconversion rate during long-term use of natalizumab

Published:2016-03-27 Issue:6 Volume:23 Page:1079-1085
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Vennegoor A.¹,van Rossum J. A.¹,Leurs C.¹,Wattjes M. P.²,Rispens T.³,Murk J. L. A. N.⁴,Uitdehaag B. M. J.¹,Killestein J.¹

Affiliation:

1. Department of Neurology; MS Centre Amsterdam; VU University Medical Centre; Amsterdam The Netherlands

2. Department of Radiology; MS Centre Amsterdam; VU University Medical Centre; Amsterdam The Netherlands

3. Landsteiner Laboratory; Sanquin Research; Amsterdam The Netherlands

4. Department of Medical Microbiology; UMC Utrecht; Utrecht The Netherlands

Funder

Biogen Idec

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12988/fullpdf

Reference23 articles.

1. The pathophysiologic role of alpha4 integrins in vivo;Lobb;J Clin Invest,1994

2. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006

3. Risk of natalizumab-associated progressive multifocal leukoencephalopathy;Bloomgren;N Engl J Med,2012

4. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab;Sorensen;Mult Scler,2012

5. JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab;Frohman;JAMA Neurol,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rates of John Cunningham virus seroconversion greatly reduced in natalizumab‐treated patients during COVID‐19‐related lockdowns;European Journal of Neurology;2023-09-14

2. Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment;Journal of Neurology;2023-03-13

3. Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-12

4. Progressive Multifocal Leukoencephalopathy;Infectious Complications in Biologic and Targeted Therapies;2022

5. Timeline and Infectious Disease Evaluation of Candidates to New Therapies;Infectious Complications in Biologic and Targeted Therapies;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3